Clinical Trial: ATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis
Study Status: Completed
Recruit Status: RECRUITING
Condition: X-linked Retinoschisis
Study Type: INTERVENTIONAL
Official Title: A Phase 1/2, Open-Label, Dose Escalation and Dose Expansion Study to Evaluate the Safety and Tolerability of ATSN-201 Gene Therapy in Male Subjects With RS1-Associated X-linked Retinoschisis
Brief Summary:
This study will evaluate the safety and tolerability of ATSN-201 in male subjects 6 to 64 years old with RS1-associated X-linked retinoschisis (XLRS).
Read more